Roche Holding Ltd. (VTX:ROG)‘s stock had its “buy” rating reaffirmed by research analysts at J P Morgan Chase & Co in a note issued to investors on Thursday.

ROG has been the subject of several other research reports. Sanford C. Bernstein set a CHF 284 price target on shares of Roche Holding and gave the company a “buy” rating in a research note on Thursday, July 27th. UBS AG set a CHF 260 price target on shares of Roche Holding and gave the company a “neutral” rating in a research note on Thursday, July 27th. Morgan Stanley set a CHF 260 price target on shares of Roche Holding and gave the company a “neutral” rating in a research note on Wednesday, July 26th. Goldman Sachs Group, Inc. (The) set a CHF 335 price target on shares of Roche Holding and gave the company a “buy” rating in a research note on Thursday, July 20th. Finally, Jefferies Group LLC set a CHF 275 price target on shares of Roche Holding and gave the company a “buy” rating in a research note on Wednesday, July 12th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and five have assigned a buy rating to the company’s stock. Roche Holding currently has a consensus rating of “Hold” and a consensus target price of CHF 263.

ILLEGAL ACTIVITY WARNING: “J P Morgan Chase & Co Reiterates Buy Rating for Roche Holding Ltd. (ROG)” was originally reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/11/02/j-p-morgan-chase-co-reiterates-buy-rating-for-roche-holding-ltd-rog.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.